Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 3
Submit an article Journal homepage
5,626
Views
58
CrossRef citations to date
0
Altmetric
Original Research

Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody

Andres Lopez-AlbaiteroDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Hong XuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Hongfen GuoDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Linlin WangDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Zhihao WuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Hoa TranDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Sarat ChandarlapatyDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Maurizio ScaltritiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Yelena JanjigianDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
,
Elisa de StanchinaAntitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA
&
Nai-Kong V. CheungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6323-5171
ORCID Icon show all
Article: e1267891 | Received 31 Aug 2016, Accepted 24 Nov 2016, Published online: 30 Mar 2017

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.